Call For Papers
The ICRBT aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Rheumatology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Biologic therapies in rheumatic disease management
- Long-term safety of biologic treatments
- Comparative effectiveness of biologics
- Patient adherence to biologic therapies
- Emerging biologic agents in rheumatology
- Cost-effectiveness of biologic treatments
- Biologics and comorbid conditions management
- Personalized medicine approaches with biologics
- Impact of biologics on disease progression
- Patient education on biologic therapies
- Challenges in access to biologic treatments
- Role of biosimilars in rheumatology
- Clinical trials of new biologic therapies
- Biologics in pediatric rheumatology
- Ethical considerations in biologic research
- Biologic therapy and quality of life
- Innovative delivery methods for biologics
- Impact of biologics on healthcare costs
- Future directions in biologic therapy research
- Collaboration between rheumatologists and researchers
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.